Lv41
410 积分 2024-09-02 加入
Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy
3分钟前
待确认
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study
6分钟前
已完结
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial
10分钟前
已完结
Can Polymetastatic Disease Be ARRESTed Using SABR? A Dosimetric Feasibility Study to Inform Development of a Phase 1 Trial
14分钟前
已完结
Ablative Radiation Therapy to Restrain Everything Safely Treatable (ARREST): A Phase 1 Study of Stereotactic Ablative Radiation Therapy for Polymetastatic Disease
1小时前
已完结
Planning Trade-offs for SABR in Patients With 4 to 10 Metastases: A Substudy of the SABR-COMET-10 Randomized Trial
1小时前
已完结
Adverse Events After Metastases-Directed Stereotactic Radiotherapy and Biological Cancer Therapy
1个月前
已完结
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials
1个月前
已完结
Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases
1个月前
已完结
Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors
1个月前
已完结
皖公网安备34019202002308
